Skip to main content
OCUL logo

OCUL · Ocular Therapeutix, Inc · Holdings

Track OCUL — free
$5.91 -0.03 (-0.51%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.31B
Shares
220.02M
Volume · Nov 19 196.64K Avg daily vol (3M) 3.04M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 266
Total Value: $1,619,636,342
Total Shares: 211,165,125
Showing 1–100 of 278 holdings by value · page 1 of 3

Institutional Ownership Trend

27 quarters

A holder reported that quarter and withheld its positions under SEC confidential treatment, which is not a sale. The line counts it at the shares it last reported; filers usually disclose the real figures about a year later.

Holder Concentration

Share of 13F common-share value, across 266 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
15.7%
Dec 2023 → Sep 2026 · range 10.3% – 16.9%
−0.1 pts
Top 5
47.3%
Dec 2023 → Sep 2026 · range 42.2% – 49.5%
+0.7 pts
Top 10
65.3%
Dec 2023 → Sep 2026 · range 58.0% – 76.1%
+0.7 pts
HHI
608
Dec 2023 → Sep 2026 · range 499 – 678
Broadly held+12

Who Holds OCUL

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 263 filers, like-for-like change +2.0%; actively managed books +2.0%; index-like books +1.7%.

Holder type Share Filers Change
Registered adviser 39.9% 126 -6.4%
Exempt adviser 1.3% 2 +1204.8%
Adviser 11.8% 10 +10.8%
Bank 5.6% 16 +8.4%
Insurer 0.0% 2 -10.8%
Broker-dealer 0.6% 3 +12.4%
Registered fund 1.0% 1 new
Benefit plan 0.2% 5 +11.4%
Non-US 1.0% 9 +43.8%
Holding company 26.4% 8 +1.1%
Unknown 12.1% 81 +1.6%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F and 3 holders with no observed 2026-09-30 13F.

Conviction and Crowding

263 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
6
2.28% of filers hold it in their top 10
Jun 30, 2026: 6
Holders above 5%
2
median weight 0.002%
Jun 30, 2026: 2
Crowding
30.4%
of shares outstanding, 80th percentile
Jun 30, 2026: 32.1%
Private-fund advisers
28.8%
of shares outstanding
Institutional ownership
96.2%
99.0% of the estimated free float
Top 10 holders
65.3%
of 13F shares, Herfindahl 0.061
Active holders
+2.0%
like-for-like share change of active filers
5% stakes on record
6
0 13D, 6 13G (4 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 14.5 quarters
Under 1 year 12.0% 1 to 3 years 28.1% 3 years or more 59.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $28,376,997 (18 buying, 13 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$8.77
estimated per share
Jun 30, 2026: $8.74
Quarter-end price
$7.67
implied by 13F values
Estimated gain or loss
-12.6%
price against the estimated cost
Estimated at a loss
91.2%
of costed 13F value

Estimated cost covers 62.4% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies OCUL's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 OLMA Olema Oncology, Inc. 7
2 XENE Xenon Pharmaceuticals Inc. 9
3 VERA Vera Therapeutics, Inc. 9
4 STOK Stoke Therapeutics, Inc. 7
5 TNGX Tango Therapeutics, Inc. 10
6 MLTX MoonLake Immunotherapeutics 7
7 ARTV Artiva Biotherapeutics, Inc. 5
8 CLDX Celldex Therapeutics, Inc. 8
9 COGT Cogent Biosciences, Inc. 10
10 MBX MBX Biosciences, Inc. 7

Shareholder Targets

13F filers that own its peers but not OCUL, quarter ended Sep 30, 2026

Found through its holder-overlap peers: OLMA, XENE, VERA, STOK, TNGX, MLTX, ARTV, CLDX, COGT, MBX, CABA, CMPX, IMVT, ERAS, ACHV, ENTX, MIRM, DNTH, ALKS, IRD. 669 filers in all.

# Filer In peers
1 Frazier Life Sciences Management, L.P. Registered adviser, Concentrated $1,569,282,261 5 held
2 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $1,297,000,883 8 held
3 RTW INVESTMENTS, LP Registered adviser, Diversified active $1,028,915,102 6 held
4 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $751,815,174 8 held
5 Polar Capital Holdings Plc Registered adviser, Diversified active $685,787,292 8 held
6 DEERFIELD MANAGEMENT COMPANY, L.P. Registered adviser, Diversified active $648,574,902 7 held
7 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $627,517,828 5 held
8 Siren, L.L.C. Unknown, Diversified active $552,288,263 7 held
9 BVF INC/IL Unknown, Concentrated $526,602,793 6 held
10 Kynam Capital Management, LP Registered adviser, Concentrated $447,700,922 5 held

Fund Ownership of OCUL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 12.76% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.94% 6,472,301
Index ETFs 9.82% 21,612,819
Active ETFs 0.40% 882,700
Active funds 13.58% 29,868,406
Unclassified 0.00% 1,702
All registered funds 26.74% 58,837,928
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
39
Increased
104
Decreased
74
Sold Out
36
Unchanged
47

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +2
Institutional value: -20.4%
Shares held: +1.9%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 278
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 278 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1393434 CUSIP 67576A100 13F (30d) 269 filings 250 filers Visit website Investor relations